IBTA vs PATH · rev $367.3M vs P/E 19, rev $1.61B
Ibotta, Inc. (IBTA) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Ibotta, Inc. (IBTA) is a software - application company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IBTA revenue for 2024-12-31 was $367.3M. Net income was $68.7M. Revenue was up 14.8% from 2023-12-31 to 2024-12-31. IBTA currently screens at market cap $764.6M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IBTA currently screens at market cap $764.6M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IBTA and PATH stock pages for the full models.
Not investment advice.